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A complex interplay of Anionic 
phospholipid Binding Regulates 
3′-phosphoinositide-Dependent-
Kinase-1 Homodimer Activation
Gloria de las Heras-Martínez1,4, Véronique calleja2, Remy Bailly3, Jean Dessolin3, 
Banafshé Larijani  4,5 & Jose Requejo-Isidro  1,6,7
3′-Phosphoinositide-dependent-Kinase-1 (PDK1) is a master regulator whereby its PI3-kinase-
dependent dysregulation in human pathologies is well documented. Understanding the direct role for 
PtdIns(3,4,5)P3 and other anionic phospholipids in the regulation of PDK1 conformational dynamics 
and its downstream activation remains incomplete. Using advanced quantitative-time-resolved 
imaging (Fluorescence Lifetime Imaging and Fluorescence Correlation Spectroscopy) and molecular 
modelling, we show an interplay of antagonistic binding effects of PtdIns(3,4,5)P3 and other anionic 
phospholipids, regulating activated PDK1 homodimers. We demonstrate that phosphatidylserine 
maintains PDK1 in an inactive conformation. The dysregulation of the PI3K pathway affects the spatio-
temporal and conformational dynamics of PDK1 and the activation of its downstream substrates. We 
have established a new anionic-phospholipid-dependent model for PDK1 regulation, depicting the 
conformational dynamics of multiple homodimer states. We show that the dysregulation of the PI3K 
pathway perturbs equilibrium between the PDK1 homodimer conformations. Our findings provide a 
role for the PtdSer binding site and its previously unrewarding role in PDK1 downregulation, suggesting 
a possible therapeutic strategy where the constitutively active dimer conformer of PDK1 may be 
rendered inactive by small molecules that drive it to its PtdSer-bound conformer.
3′-Phosphoinositide-dependent-Kinase-1 (PDK1) propagates extracellular signals downstream of Phosphoinositide 
3-kinase (PI3K) through the phosphorylation of a plethora of AGC kinases involved in growth, survival and 
cell motility1,2. PDK1 has many kinase-dependent and independent functions, and fulfils the criteria of being 
a master regulator of proliferative signalling. The physiological evidence is clear as alteration in PDK1 expres-
sion or activity have been found many types of cancer3. PDK1 can associate with the plasma membrane (PM) 
by interaction with phosphatidylinositol (3,4,5) trisphosphate (PtdIns(3,4,5)P3), phosphatidylinositol (4,5) bis-
phosphate (PtdIns(4,5)P2) and phosphatidylserine (PtdSer) via its pleckstrin homology (PH) domain4–6, and 
through other adaptor proteins such as Grb147, Grp788 and Freud-1/Aki19. Despite being mainly localised in 
the cytoplasm and at the PM, pools of PDK1 have been detected in the nucleoplasm where many of its substrates 
also reside10–13. The high-affinity specific interaction of PDK1 with PtdIns(3,4,5)P3 through its K465 residue on 
its PH domain has been well established5,14,15. However, reports on whether PtdIns(3,4,5)P3 is solely responsible 
for PDK1 recruitment to the PM are contradictory4,6,16, suggesting a complex interplay between PDK1 binding 
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to phosphoinositides and other anionic phospholipids. PtdSer is the predominant anionic species and is present 
at higher concentrations than the phosphoinositides at the inner leaflet of the PM17. PtdSer has been reported to 
be involved in the membrane localisation of PDK1 through its basic residues R466 and K4676 but the role of this 
interaction has not yet been fully elucidated. Besides, it has been shown that PDK1 is constitutively active since 
it is phosphorylated on its activation loop at S241 and is active in vitro18. However, it was also shown in situ that 
PDK1 itself could be regulated upon stimulation19,20. More recently, PtdIns(3,4,5)P3 binding to PDK1 in live cells 
was shown to elicit the formation of PDK1 homodimers13,19 and to trigger the autophosphorylation of the PDK1 
PH domain residue 513. This, was suggested to be due to the disruption of an autoinhibitory PDK1 homodimer 
conformer13,21,22, although this mechanism still remains to be defined.
These findings pointed towards an elaborate fine-tuning of PDK1 conformational dynamics upon stimula-
tion in cells that involve the interaction with negatively charged lipids such as PtdIns(3,4,5)P3, PtdIns(4,5)P2 
and PtdSer, autophosphorylation of T513 and homodimerisation. However, our understanding of the interplay 
between these events and the associated regulation that enables the phosphorylation of PDK1 substrates remains 
largely unknown. Addressing these issues has been hampered by the lack of suitable in situ quantitative methods 
for interrogating the spatio-temporal sequence of protein-lipid interactions. For this reason, we recently devel-
oped a precise and well-resolved quantitative imaging method based on FRET-FLIM (Förster Resonance Energy 
Transfer - Fluorescence Lifetime Imaging) that overcomes these technical obstacles23. In this work, we have been 
able to monitor in situ the anionic phospholipid-mediated regulation of PDK1 homodimerisation and localisa-
tion leading to PDK1 activation, and how this is linked to T513 autophosphorylation in cells with a normal or 
a dysregulated PI3K pathway. Using the methodology we have recently developed23, we unravelled three major 
mechanisms for PDK1 regulation. Firstly, that PDK1 homodimerises in an activated conformation phospho-
rylated on T513 and is capable of activating downstream substrates like PKB/Akt and SGK1. Secondly, that this 
homodimer formation is triggered by two opposite mechanisms: (i) The binding to PtdIns(3,4,5)P3 upon growth 
factor stimulation, and (ii) the loss of PM binding to other anionic phospholipids. This suggested a competitive 
regulatory mechanism involving PtdIns(3,4,5)P3 and other anionic phospholipids having opposing effects on 
PDK1 activation. Thirdly, we have demonstrated that PDK1 activation through recruitment to the PM is not only 
dependent on its PH domain but its kinase domain plays a prominent role in this process. The role of the kinase 
domain interaction is of particular importance in cells with a dysregulated PI3K pathway and an aberrant regula-
tion of the PtdIns(3,4,5)P3 levels, leading to an abnormal PDK1 activation.
Results
Characterisation of anionic lipids binding to PDK1 PH domain in vitro. The nature of PDK1 inter-
actions and regulation by anionic phospholipids at the PM remains a subject of discussion. To understand the 
mechanism of interplay of the anionic phospholipids associations with PDK1, we characterised their in vitro 
interactions using fluorescently tagged PH domains of PDK1 (PHPDK1). PHPDK1 wild type (WT) and mutants 
binding to specific lipid species was tested using a protein-lipid overlay assay, while the nature of their associ-
ation to the bilayer was studied through their diffusional behaviour using single-focus scanning Fluorescence 
Correlation Spectroscopy (sFCS)24,25 (Figs 1 and S1). The positively charged amino acid site 465, previously asso-
ciated with PtdIns(3,4,5)P3, and 466/467, associated with PtdIns(4,5)P2 and PtdSer binding5,6, were mutated to 
the neutral residues alanine (K465A and R466A/K467A) (Figs S2A and S3). As a preliminary indication we uti-
lised a protein-lipid overlay assay, to determine the PHPDK1 affinity for PtdIns(3,4,5)P3, PtdIns(4,5)P2 and PtdSer. 
Although this assay does not reflect the physiological behaviour of the PH domains towards the anionic lipids, 
it is still indicative of their in vitro binding affinity. We showed that WT-PHPDK1 bound PtdIns(3,4,5)P3 with a 
high affinity and PtdIns(4,5)P2 to a lesser extent (Fig. 1A). In line with previous reports, detectable interactions 
with PtdIns(3,4,5)P3 or PtdIns(4,5)P2 were not observed with the K465A-PHPDK1 mutant even during extended 
incubations5. The R466A/K467A-PHPDK1 mutant, however, selectively lost its binding to PtdIns(4,5)P2 but not to 
PtdIns(3,4,5)P3.
Since the residues R466/K467 were previously proposed to be necessary for PDK1 interaction with PtdSer6 
we investigated the binding properties of the different mutants with this phospholipid. PtdSer binding to PHPDK1 
was only detected after a 40-fold increase of the amount of lipid (from 100 pmol in Fig. 1A to 4 nmol in Fig. 1B), 
demonstrating that the in vitro PHPDK1 affinity for PtdSer was significantly lower than PtdIns(3,4,5)P3. The muta-
tion K465A did not affect binding to PtdSer, while the mutation R466A/K467A showed a four-fold reduction in 
affinity. These data suggested that despite the close proximity of these three residues (K465, R466A and K467A) 
on the PDK1 PH domain, their different binding properties enabled to discriminate the effect of PtdIns(3,4,5)P3 
from the other anionic phospholipids.
We next determined whether post-translational modifications of the PH domain could also regulate PDK1 
binding to the PM by affecting its association with anionic phospholipids. We and others had previously shown 
that PDK1 activation was dependent on the autophosphorylation of the PH domain residue T513 upon PM 
translocation13,21,24. Therefore, we examined whether T513 phosphorylation affected the binding of PHPDK1 to ani-
onic phospholipids. To this aim we prepared a PHPDK1 mutant that mimicked PHPDK1 phosphorylation on T513 
(T513E-PHPDK1)24. Figure 1A shows that even though T513E-PHPDK1 retained some ability to bind PtdIns(3,4,5)
P3 it required an extended incubation time to be detected, reflecting a lower affinity for this lipid compared to the 
wild type species. In addition, T513E-PHPDK1 did not bind PtdSer even at the highest concentrations (Fig. 1B). 
These experiments suggested that the autophosphorylation of the PDK1 PH domain residue 513 upon stimula-
tion could trigger a loss of affinity of the activated PDK1 for the PM.
To further understand the nature of the PDK1 – anionic lipid interaction we studied PHPDK1 associa-
tion and diffusion on giant unilamellar vesicles (GUV) composed of DOPC (1,2-di-(9Z-octadecenoyl)-sn
-glycero-3-phosphocholine), PtdIns(3,4,5)P3 (PIP3) and PtdSer (1-hexadecanoyl-2-(9Z-octadecenoyl)-
sn-glycero-3-phospho-L-serine, POPS) mixed at varying proportions using sFCS (Methods and Fig. S1). 
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Diffusion of a protein on a lipid bilayer depends largely on the lipid-protein electrostatic interactions. A protein 
tightly bound to an individual lipid through a stereospecific, lipid-specific, interaction diffuses at the same rate as 
the lipid irrespective of the surface potential of the vesicle26. However, a protein associated to the vesicle through 
non-specific electrostatic interactions slides on the GUV surface faster than individual lipids in the mixture, since 
its diffusion is, in this case, subject only to the charge-driven attraction between the protein positive patches and 
the GUV negatively charged surface. Consequently, the diffusion coefficient of the protein is only effected by 
modulation of the membrane surface potential in the latter case, but not in the former26. In this sense the diffu-
sion of a protein on a model membrane does not relate directly to protein function, but provides information on 
protein-membrane interaction, which is later correlated to its function.
Confocal microscopy of the GUVs showed that wild type PHPDK1 readily bound the outside layer of a 
GUV containing only 3% PtdIns(3,4,5)P3 (DOPC:POPS:PIP3 67:30:3), but binding was not detected when 
PtdIns(3,4,5)P3 was absent from the mixture (DOPC:POPS 70:30 GUVs) (Fig. 1C). This behaviour reflected the 
results obtained from the protein-lipid overlay assay.
The diffusion coefficient of WT-PHPDK1 on DOPC:PIP3 (97:3) vesicles was 8.3 ± 0.5 µm2 s−1 (Fig. 1D) which 
is highly consistent with the reported diffusion coefficient of individual lipids in fluid mixtures27, suggesting a 
Figure 1. Characterisation of anionic lipids binding to PDK1 PH domain in vitro (A). Lipid protein-overlay 
assays showing the binding of WT-PHPDK1 and mutants to a selection of lipids spotted on nitrocellulose. 
(B) PHPDK1 wild type and mutants’ affinity for PtdSer. (C) Confocal images of WT-PHPDK1 association to 
GUVs of different compositions. (D) WT-PHPDK1 and mutant T513E-PHPDK1 diffusion on GUVs of different 
composition. (E) Representative autocorrelation curves from sFCS experiments, each corresponds to one GUV. 
N > 8. Box: 2xSEM (Standard Error of the Mean); Whiskers: 80% population. Mann-Whitney test *p < 0.05.
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lipid-specific association of WT-PHPDK1 to PtdIns(3,4,5)P3 that was later confirmed (below). Given the weak bind-
ing of PHPDK1 to PtdSer compared to PtdIns(3,4,5)P3 (Fig. 1B), and that association of PHPDK1 to DOPC:POPS 
(70:30) GUVs was not observed, we did not anticipate any effect of PtdSer in the diffusion of PHPDK1. We found, 
however, that PHPDK1 diffused faster on PtdIns(3,4,5)P3-containing GUVs that lacked PtdSer (DOPC:PIP3 
97:3, diffusion coefficient 8.3 ± 0.5 µm2 s−1) than on GUVS that contained POPS and the same mole fraction 
of PtdIns(3,4,5)P3, (DOPC:POPS:PIP3 67:30:3, diffusion coefficient 6.5 ± 0.4 µm2 s−1, Fig. 1D). This indicated 
that PtdSer was able to bind PHPDK1 only in combination with PtdIns(3,4,5)P3 binding. This dual association 
maybe due to either the binding of the 2 anionic phospholipids to the same PH domain or to the formation of 
a dimeric conformation where each lipid would bind one PH domain (sFCS alone would not be able to distin-
guish between a monomeric PH conformer versus a dimeric PH conformer). We did not observe any change 
in the diffusion of PHPDK1 on DOPC:POPS:PIP3 GUVs when the mole fraction of the polyvalent, highly neg-
ative PtdIns(3,4,5)P3 was increased from 3% to 10% (6.5 ± 0.4 µm2 s−1 and 6.6 ± 0.3 µm2 s−1), confirming that 
PHPDK1 bound PtdIns(3,4,5)P3 in a lipid-specific manner, rather than by a non-specific, charge-driven, interac-
tion. Finally, the phosphomimetic T513E-PHPDK1 mutant diffused in a similar manner in GUVs with different 
lipid compositions and showed faster diffusion than WT-PHPDK1 in DOPC:PIP3 GUVs (Fig. 1Db,d,f). Since the 
affinity of T513E-PHPDK1 for PtdIns(3,4,5)P3 was very low, and negligible for PtdSer, this behaviour indicated the 
predominance of non-specific, electrostatically driven attraction of T513E PHPDK1 positive patches to the nega-
tively charged vesicle surface.
Opposing effects of anionic phospholipids regulate the formation of activated PDK1 homod-
imers. Having established the in vitro binding properties of the different PDK1 phospholipids mutants and 
determined the effect of PtdSer on the binding of PDK1 PH domain to PtdIns(3,4,5)P3, we examined the interplay 
of these lipids in the regulation of full-length PDK1 in cells. To this end, we analysed the activation potential of 
wild type PDK1 and relevant PDK1 mutants through the study of their localisation and conformational dynam-
ics. An activated PDK1 conformer refers, in this context, to the molecular conformation that enables the phos-
phorylation of its downstream targets.
We had previously reported PDK1 homodimerisation in response to growth factor stimulation13. However, in 
our previous work, the interacting population of PDK1 had not been directly determined. In this investigation we 
directly quantified the interacting population of full-length protein PDK1 homodimers in situ using quantitative 
FRET-FLIM (Supplementary Methods and Fig. S4). FRET was detected by FLIM as the energy transfer from 
ectopically expressed eGFP-myc-PDK1 (donor) to HA-PDK1-mCherry (acceptor) (Fig. S2B). Here, based on 
fluorescence lifetime analysis we determined the effective fraction of donor undergoing FRET, fD
eff , for every cell 
(Fig. S4A,B) and defined the Dimerisation Efficiency (ED). As opposed to the FRET efficiency, which is dependent 
on the relative abundance of interacting partners, ED directly accounts for cell-to-cell variations in donor and 
acceptor concentration (Fig. S4C–E). With this methodology, ED allows comparison between cells, while fD
eff , 
which can be determined for every pixel in the cell, allows comparison between regions in the same cell.
Due to the limited resolution of optical microscopy, protein translocation to the PM cannot be reliably 
assessed from visual inspection of confocal images, especially in the case of weak translocation. For this reason, 
to obtain a quantitative measurement of the recruitment of total PDK1 and dimeric PDK1 at the PM in response 
to growth factor stimulation we utilised image segmentation methods on intensity and FRET-FLIM images to 
determine the spatial localisation of PDK1 as well as the localisation of PDK1 homodimers, respectively (Figs S4F 
and S5). We compared the ratio of PDK1 fluorescent intensity at the PM to the intensity at the cytoplasm (PM/
Cyt) to that of a cytoplasm targeted construct (freely diffusing mCherry-6Gly-EGFP) and to a membrane-targeted 
construct (a Lyn N-terminal sequence fused to a FKBP domain, Lyn11-FKBP-FKBP-mRFP28). Finally, segmenta-
tion of the FRET-FLIM images allowed computation of the fD
eff  ratio at the PM and cytoplasm, which is a meas-
urement of the localisation of the molecules undergoing FRET. As a reference for the relative PM/Cyt distribution 
of GFP-PDK1 – mCherry-PDK1 dimers we used the inherently FRETting mCherry-6Gly-EGFPT construct23. All 
these reference translocation levels are indicated in Table 1.
Initially, we analysed GFP-PDK1 and PDK1-mCherry recruitment at the PM in NIH3T3 cells irrespective 
of their dimerisation status by segmentation of the intensity images (Fig. 2A). As compared to the membrane- 
and cytoplasm- targeted reference controls (PM/Cyt intensity 2.2 ± 0.1 and 0.84 ± 0.1 respectively), intensity 
segmentation indicated a predominantly cytoplasmic distribution of GFP-PDK1 and PDK1-mCherry in rest-
ing NIH3T3 cells (Fig. 2B). PDK1 translocated weakly to the PM following an increase of PtdIns(3,4,5)P3 upon 
platelet-derived growth factor (PDGF) stimulation, and this was prevented by the PtdIns(3,4,5)P3-binding site 
mutation K465A. In all cases, PDK1 recruitment to the NIH3T3 PM was compromised when PI3K was inhib-
ited by LY294002 prior to stimulation. Nevertheless, despite the weak affinity of the isolated PH domain mutant 
T513E for PtdIns(3,4,5)P3 and other phospholipids in vitro (Fig. 1), full-length PDK1-T513E recruited to the PM 
upon PDGF stimulation. This result suggested a potential role for PDK1 kinase domain, either directly binding to 
the PM or by an allosteric effect on the PH domain affinity for the PM.
The mutation of the PDK1 PH domain residues R466A/K467A had been previously described to impair the 
binding of PDK1 to PtdSer and the localisation at the PM of NIH3T3 cells6. Our in vitro experiments showed that, 
in addition to PtdSer, the mutation also precluded the binding to PtdIns(4,5)P2 (Fig. 1A). Nonetheless the overall 
localisation of full-length GFP-PDK1 and PDK1-mCherry in NIH3T3 cells was not affected by the R466A/K467A 
mutation (Fig. 2Bf–h).
Next, we monitored the homodimerisation of PDK1 by acquiring, in situ, full-length GFP-PDK1 and 
PDK1-mCherry wild type and mutants homodimerisation by FRET-FLIM. We observed that dimer formation 
(Fig. 2C) and dimer localisation (Fig. 2D) were not systematically following the localisation pattern determined 
for the total amount of protein, described above (observations for total protein, based on intensity measurements, 
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did not take into account whether the protein was in a dimer form). The ED values for WT PDK1 showed an 
increase of PDK1 homodimerisation in response to growth factor (PDGF) stimulation, while it remained at 
basal level when PI3K was inhibited by LY294002 prior to stimulation. Consistent with the latter, the loss of 
PtdIns(3,4,5)P3 binding (K465A) precluded the strong dimerisation of PDK1 upon PDGF stimulation. A small 
increase in ED was still detected possibly due to unspecific electrostatic interactions (Fig. 2Cd-e).
Mimicking PDK1 phosphorylation with the PH domain mutation T513E had been shown to increase PDK1 
activity13,24. Additionally, residue 513 phosphorylation is known to relieve a PDK1 autoinhibitory conformation21. 
This led to the hypothesis that T513 phosphorylation induced a disruption of PDK1 autoinhibited homodimers 
resulting in the formation of active PDK1 monomer13,21. However, by determining the ED we illustrate here that 
T513E mutation did not prevent PDK1 homodimerisation (Fig. 2Ci–k) and that the dimer regulation was similar 
to the WT-PDK1. This demonstrated that the activation of PDK1 by phosphorylation at 513 did not induce PDK1 
monomers but resulted in an enhancement of PDK1 homodimer population.
The loss of PtdSer and PtdIns(4,5)P2 binding through the R466A/K467A mutation did not prevent PDK1 
homodimerisation (Fig. 2Cf–h). On the contrary, the population of R466A/K467A-PDK1 dimers was signifi-
cantly higher than the WT-PDK1 in basal conditions and did not change upon either growth factor stimulation 
or PI3K inhibition. Since the constitutive formation of the R466A/K467A-PDK1 homodimers was independ-
ent of the modulation of PI3K, these data suggested that R466A/K467A-PDK1 homodimer formation, unlike 
WT-PDK1, occurred through a mechanism independent of its binding to PtdIns(3,4,5)P3 and other anionic 
phospholipids.
To understand the mechanisms of PDK1 homodimer formation, we specifically analysed their subcellular 
localisation. Image segmentation of the FRET-FLIM images allowed the PM/Cyt ratio of GFP-PDK1 and 
PDK1-mCherry FRET fraction ( fD
eff ) to be computed, revealing differences between the localisation of PDK1 
homodimer and total PDK1 (irrespective of its homodimerisation status). Segmentation of the FRET-FLIM 
images (Fig. 2D) demonstrated that WT-PDK1 dimers were recruited to the PM in NIH3T3 upon the increase of 
PtdIns(3,4,5)P3 levels. The localisation of the PDK1 mutants that did not bind PtdIns(3,4,5)P3 via their PH 
domain (K465A) revealed that they were still retained at the PM in basal conditions, indicating that the localisa-
tion of the PDK1 homodimers was due to PM interactions involving other factors than the binding of the PH 
domain to PtdIns(3,4,5)P3. The localisation of the T513E mutant followed the pattern of the wild type protein, 
suggesting that the mechanisms involved in the formation of the WT and T513E-PDK1 homodimers were simi-
lar. The R466A/K467A-PDK1 dimers did not localise to the PM even after growth factor stimulation but they 
predominantly localised in the cytoplasm. Therefore, the R466A/K467A-PDK1 mutant behaviour suggests a dif-
ferent mechanism for the formation of PDK1 homodimers.
Our results demonstrated that the increased formation of PDK1 homodimers was not only the result of 
growth factor stimulation, but could also occur in a constitutive manner due to mutation. We therefore deter-
mined the activation status of WT-PDK1 and its mutants. Our results had also shown that the activating mutant 
T513E-PDK1 was also a homodimer, raising the possibility that the homodimer conformer of PDK1 would be 
activated and capable of phosphorylating downstream targets. Therefore, we monitored the effect of the mutants 
on the phosphorylation of Akt/PKB, a PDK1 substrate. Figure 2E shows the direct activation of Akt/PKB by 
PDK1 reported by the phosphorylation of the T308 residue in Akt/PKB’s activation loop. Phosphorylation of 
Akt/PKB by WT-PDK1 increased upon PDGF stimulation. This increase correlated with the augmentation of 
WT-PDK1 homodimers and their localisation at the PM (Fig. 2Cb,Db). PDK1 PtdIns(3,4,5)P3-binding defective 
mutant K465A moderated T308 phosphorylation increase upon stimulation, but did not abolish it completely. 
This also correlated with K465A-PDK1 basal localisation at the PM and residual formation of these mutant 
homodimers upon stimulation (Fig. 2Bd,Cd).
Both the activating T513E-PDK1 and the PM localisation-defective R466A/K467A-PDK1 triggered an 
increase in T308 phosphorylation upon stimulation that was similar to WT-PDK1 (Fig. 2E). This also correlated to 
WT-PDK1, T513E and R466A/K467A elevated homodimer formation, despite their different localisation patterns 
(Fig. 2C,D). It is important to note that, irrespective of PDK1 homodimerisation status, Akt/PKB requires prior 
binding to PtdIns(3,4,5)P3 before being phosphorylated by PDK1 at T30810. Therefore, in resting conditions or 
after PI3K inhibition, Akt/PKB phosphorylation was reduced despite the increased levels of PDK1 homodimers 
Pixel size 
(nm)
Cytoplasm targeted Membrane targeted
Free-diffusing mCherry-6Gly-EGFP Lyn11-FKBP2-mRFP
EGFP
PM/Cyt intensity
mCherry
PM/Cyt intensity
FRET-FLIM
fD
eff  PM/Cyt
mCherry channel
PM/Cyt intensity
275 0.84 ± 0.01 0.85 ± 0.01 1.04 ± 0.01 2.2 ± 0.1
68 0.99 ± 0.01 0.98 ± 0.01 — 2.7 ± 0.1
Table 1. Translocation reference levels for cytoplasm- and membrane-targeted fluorescent control constructs 
measured through the EGFP, mCherry, and FRET-FLIM imaging detectors (supporting methods) at different 
pixel sizes. 275 nm pixel-size images were acquired for FRET experiments (Figs 2–5), while 68 nm pixel-size 
images were acquired for the quantification of PtdIns(3,4,5)P3 levels (Fig. S6). The difference between PM/Cyt 
intensity values for 275 nm and 68 nm pixel size is due to the lower resolution of the former. fD
eff  PM/Cyt is the 
PM to cytoplasm fD
eff  ratio, which quantifies the relative distribution of FRETting pairs. The uncertainty is 
indicated as SEM for at least N > 20.
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Figure 2. Opposing effects of anionic phospholipids regulate the formation of active PDK1 homodimers. All 
experiments were performed under resting conditions (−), stimulation of the PI3K pathway with PDGF (+) or 
treated with the PI3K inhibitor (LY294002) prior to stimulation. NIH3T3 cells were cotransfected with GFP-
PDK1 and PDK1-mCherry. (A) Representative intensity and FRET-FLIM fD images. (B) Relative distribution of 
PDK1 at the PM and the cytoplasm of NIH3T3 cells. The dashed line indicates the reference level for a control 
cytoplasmic protein (Table 1). (C) Quantification of the homodimerisation efficiency of PDK1 wild type and 
mutants. ED calculation is based on FRET-FLIM measurements on a single-cell level, as illustrated in (A). (D) 
Localisation of the PDK1 homodimers in NIH3T3 cells. The graph shows the ratio of PDK1 dimers at the PM 
and the cytoplasm based on the segmentation of the fD images shown in (A). (E) Phosphorylation of Akt/PKB 
at T308 in NIH3T3 cells. The upper panel shows a representative western blot of phosphorylated Akt/PKB on 
T308 and of total Akt/PKB (pan AKT). The bars show the ratio of T308 phosphorylation over total protein. The 
data were normalised to the condition basal wild type PDK1. Scale bar: 20 µm. (B) N > 30. Error bars: SEM. 
(C,D) N > 30. Box: 2xSEM (95.4% confidence); Whiskers: 80% population. Mann-Whitney test *p < 0.05. (B-E) 
Three independent experiments.
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(Fig. 2Eg,i,Cf,h). Both T513E and R466A/K467A mutations induced a slightly higher basal phosphorylation of Akt/
PKB compared to WT, reinforcing the notion that PDK1 activation followed closely its homodimerisation status.
Taken together, these data suggested that growth factor stimulation was promoting the formation of active 
PDK1 homodimers through binding to PtdIns(3,4,5)P3 at the PM, although the homodimerisation and localisa-
tion patterns of PDK1 mutants hinted to the existence of a more nuanced regulation mechanism. We suggest an 
alternative mechanism whereby the formation of active PDK1 homodimers may bypass binding to PtdIns(3,4,5)
P3. We propose that PtdIns(3,4,5)P3 and other anionic phospholipids concurred to localise PDK1 at the PM but 
their differential binding triggered opposite effects on PDK1 regulation. PtdIns(3,4,5)P3-binding induced a con-
formation that was conducive to PDK1 and downstream substrates activation, whereas the binding to anionic 
phospholipids other than PtdIns(3,4,5)P3 maintained PDK1 in an inactive conformation at the PM.
Figure 3. In PI3K-dysregulated cells, PDK1 homodimerisation and localisation is independent of PtdIns(3,4,5)
P3 levels. All experiments were performed under resting conditions (−), stimulation of the PI3K pathway with 
EGF (+) or treated with the PI3K inhibitor (LY294002) prior to stimulation. SKBR3 cells were cotransfected 
with GFP-PDK1 and PDK1-mCherry. (A) Representative intensity and FRET-FLIM fD images. (B) Relative 
distribution of full-length PDK1 at the PM and the cytoplasm of SKBR3 cells. The dashed line indicates 
the reference level for a control cytoplasmic protein (Table 1). (C) Quantification of the homodimerisation 
efficiency of full-length WT PDK1 and its mutants. ED calculation is based on FRET-FLIM measurements on 
a single-cell level, as illustrated in (A). (D) Localisation of the PDK1 homodimers in SKBR3 cells. The graph 
shows the ratio of PDK1 dimers at the PM and the cytoplasm based on the segmentation of the fD images shown 
in (A). Scale is 20 µm. N > 30. Error bars: SEM. (C,D) N > 30. Box: 2xSEM; Whiskers: 80% population. Mann-
Whitney test *p < 0.05. Three independent experiments.
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To understand the dynamics of anionic phospholipids associated to the mechanism of PDK1 regulation, we 
took advantage of a cell line with a dysregulated PI3 kinase and an altered phosphoinositide composition. SKBR3 
cells are a breast cancer cell line with overexpressed levels of HER2 inducing anomalies in the PI3 kinase pathway. 
First we investigated the modulation of PtdIns(3,4,5)P3 by growth factor stimulation and PI3K inhibition and the 
PtdSer levels in these cells. This, in turn, was compared to how these anionic phospholipids affected the formation 
of dimers of PDK1 and its mutants in SKBR3.
Determination of the relative in situ levels of PtdIns(3,4,5)P3 by GRP1 PH domain. To test 
how the aberrant behaviour of the HER2 growth factor receptor pathway in SKBR3 cells affected the levels of 
PtdIns(3,4,5)P3, as compared to NIH3T3 cells, we used an in situ intensity segmentation method to quantify 
PtdIns(3,4,5)P3 levels (Fig. S6). In these experiments, we specifically chose a PH domain probe with a relatively 
low affinity for PtdIns(3,4,5)P3 detection (GFP-GRP1PH)29. The lower affinity of this probe (KD ≈ 50 nM30), com-
pared to PHPDK1, (KD ≈ 0.2 nM31) reduced the cytoplasmic sequestration of PtdIns(3,4,5)P3 and thus provided a 
Figure 4. The homodimerisation and localisation of PDK1 PH domain follows PtdIns(3,4,5)P3 levels, contrary 
to full-length PDK1. All experiments were performed under resting conditions (−), stimulation of the PI3K 
pathway with EGF (+) or treated with the PI3K inhibitor (LY294002) prior to stimulation. SKBR3 cells were 
cotransfected with GFP- and mRFP- tagged PHPDK1. (A) Representative intensity and FRET-FLIM fD images. 
(B) Relative distribution of PHPDK1 at the PM and the cytoplasm of SKBR3 cellx. The dashed line indicates 
the reference level for a control cytoplasmic protein (Table 1). (C) Quantification of the homodimerisation 
efficiency of WT PHPDK1 and its mutants. (D) Localisation of the PHPDK1 homodimers in SKBR3 cells. The graph 
shows the ratio of PHPDK1 dimers at the PM and the cytoplasm based on the segmentation of the fD images 
shown in (A). Scale is 20 µm. N > 30. Error bars: SEM. (C,D) N > 30. Box: 2xSEM; Whiskers: 80% population. 
Mann-Whitney test *p < 0.05. Three independent experiments.
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more accurate representation of endogenous levels of PtdIns(3,4,5)P3 at the PM. PtdIns(3,4,5)P3 levels at the PM 
upon stimulation of the PI3K pathway were higher in SKBR3 cells than in NIH3T3 cells (23% and 8% increase rel-
ative to the basal state, respectively) (Fig. S6C,D). PI3K inhibition (LY294002) prior to stimulation resulted in the 
decrease of PtdIns(3,4,5)P3 levels at the PM below the basal levels observed in NIH3T3 cells, while they remained 
at the basal level in SKBR3 cells. The GFP-GRP1PH probe followed the same behaviour in starved and non-starved 
SKBR3 cells (Fig. S6E). The control binding-defective GRP1 PH domain mutants did not bind to PtdIns(3,4,5)
P3. These data showed that, unlike NIH3T3 cells, the basal level of PtdIns(3,4,5)P3 in SKBR3 was not affected by 
Figure 5. Akt/PKB heterodimerisation with PDK1 and downstream activation correlates with the level of 
PDK1 homodimerisation in SKBR3 cells. (A) Representative intensity and FRET-FLIM images of SKBR3 cells 
co-transfected with mCherry-Akt/PKB and GFP-PDK1. (B) The efficiency of mCherry-Akt/PKB and GFP-
PDK1 interaction determined by FRET-FLIM in SKBR3 cells increases upon growth-factor stimulation and 
is highest for R466A/K467A PDK1 mutant. (C) Phosphorylation of Akt/PKB at T308 correlates well with the 
efficiency of Akt/PKB and PDK1 heterodimerisation. (D) Phosphorylation of endogenous SGK1 at its T-loop by 
PDK1 is potentiated by the mutation R466A/K467A. (A) Scale bar: 20 µm. (B) N > 30. Box: 2xSEM; Whiskers: 
80% population. Mann-Whitney test *p < 0.05. Three independent experiments. (C–D) n = 3. Error bars: SEM.
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PI3K inhibitor (LY294002). This suggested either an additional PI3K independent source of PtdIns(3,4,5)P3 or 
that elevated PtdIns(3,4,5)P3 was a consequence of enhanced receptor tyrosine kinase activity in SKBR3 cells and 
the residual uninhibited PI3K. In summary, the regulation of the PtdIns(3,4,5)P3 levels was altered in SKBR3 cells.
These results were also independently confirmed in live cell experiments using the same quantification 
method for PtdIns(3,4,5)P3. That is, PtdIns(3,4,5)P3 levels increased upon stimulation at the PM and were 
reduced below basal level upon PI3K inhibition in NIH3T3 but not in SKBR3 cells (Fig. S7).
Figure 6. Molecular modelling of PDK1 PH domain homodimers and model of PDK1 homodimers activation. 
(A) Docking of PtdIns(3,4,5)P3 (left panel) and PtdSer (right panel) on PDK1 PH domain. Residue K465 
is in yellow. (B,C) Representation of the three possible PDK1 PH domain homodimers bound to anionic 
phospholipids. (D) Model of the predicted active and inactive PDK1 homodimer conformers and their 
interaction with downstream substrates.
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PtdSer levels in both cell lines were also quantified using a genetically encoded fluorescently labelled PtdSer 
sensor32 (mCherry-Lact-C2) fused to a self-cleaving P2A peptide and to GFP33. This way mCherry-Lact-C2 
and free-diffusing GFP were expressed at the same rate, allowing ratiometric imaging of the sensor. We did 
not observe any growth factor stimulation-related differences in localisation to the PM of the PtdSer biosensor 
(Fig. S8). These data demonstrated that the levels of PtdSer were not significantly modified by stimulation or 
inhibition of the PI3K pathway in both cell lines.
In dysregulated PI3K cells, PDK1 homodimerisation and localisation was independent of its PH 
binding to PtdIns(3,4,5)P3 and PtdIns(3,4,5)P3 levels. Having measured the changes in PtdIns(3,4,5)
P3 levels between the two cell lines, we next monitored the dynamic regulations of PDK1 in SKBR3 cells, where 
a different behaviour from NIH3T3 cells was identified. All PDK1 variants showed a strong constitutive associa-
tion with the PM (Fig. 3A,B); this was also consistent for the PtdIns(3,4,5)P3 binding-defective (K465A) and the 
R466A/K467A PDK1 mutants. PI3K inhibition prior to stimulation did not affect the recruitment of any of the 
PDK1 variants to the SKBR3 PM (Fig. 3B). A prominent PM localisation was observed for the homodimer con-
formers, including mutant R466A/K467A-PDK1, whereas in NIH3T3 cells, these were localised preferentially in 
the cytoplasm (Fig. 2B). Our results had indicated that in NIH3T3 cells the localisation of PDK1 (irrespective of 
its dimerisation status) was dependent on the transient production of PtdIns(3,4,5)P3 at the PM (Fig. 2B), while 
in SKBR3 cells PDK1 localisation was constitutively at the PM and did not change significantly, either through 
PDK1 PH domain mutation (K465A) or upon PI3K stimulation or inhibition (Fig. 3B). This suggested that the 
overall localisation of PDK1 was independent of the transient formation of PtdIns(3,4,5)P3. Furthermore, the 
double mutation R466/K467 to alanine did not prevent PDK1 from translocating to the PM in SKBR3 nor in 
NIH3T3 cells, indicating events other than anionic lipids binding to the PH domain were involved in PDK1 
recruitment.
Our next step entailed interrogating how the constitutive PM localisation would influence the formation 
of PDK1 homodimers in dysregulated SKBR3 cells. Figure 3C shows that WT-PDK1 responded to epidermal 
growth factor (EGF) stimulation shown by the increase of the homodimer population. However, PI3K inhibition 
did not prevent EGF-stimulated increase in WT-PDK1 homodimers (Fig. 3Cc). This result was not due to a lack 
of effect of the PI3K inhibitor, since it blocked EGF-induced PtdIns(3,4,5)P3 increase in SKBR3 cells (Fig. S6D,E 
and S7). It rather implied that, while the increase in homodimers was dependent on EGF stimulation, it was 
independent of transient formation of PtdIns(3,4,5)P3. The unexpected behaviour of the PDK1 mutants showed 
a significant increase in the basal homodimerisation compared to WT-PDK1 (Fig. 3C).
The fact that PDK1 was able to homodimerise independently of variations in PtdIns(3,4,5)P3, and that none 
of the PH domain mutations affected the binding of full-length PDK1 to the PM, pointed towards a critical role 
for the kinase domain in the regulation of PDK1 localisation and dynamics. To test this hypothesis, we investi-
gated how isolated PDK1 PH domains in SKBR3 cells would recruit and dimerise at the PM. To this end, the cells 
were co-transfected with GFP-PHPDK1 and mRFP-PHPDK1 (Fig. 4A). The isolated WT PHPDK1 localised at the PM 
analogous to full-length PDK1 in these cells (Fig. 4B). However, contrary to the full-length protein, their relative 
PM/Cytoplasm distribution was modulated by PtdIns(3,4,5)P3 varying levels upon growth factor stimulation 
and PI3K inhibition. The K465A PH-domain mutant did not respond to increased PtdIns(3,4,5)P3 as expected 
from the in-vitro experiments. All the mutations affected the localisation of the PH domains to the PM, with the 
mutation R466A/K467A having the strongest effect (Fig. 4B).
Direct assessment of the wild type PHPDK1 homodimerisation in SKBR3 cells showed that, contrary to the 
full-length protein (Fig. 3C), PHPDK1 homodimerisation was strictly PtdIns(3,4,5)P3-dependent (Fig. 4C). EGF 
stimulation induced the production of WT-PHPDK1 dimers, inhibited by pretreatment with LY294002. The loss of 
PtdIns(3,4,5)P3 binding in the K465A mutant prevented the formation of homodimers upon stimulation. Similar 
to the wild type, the activating mutant PH domain (T513E) dimers were formed upon stimulation. The mutation 
of the R466/K467 residues totally abolished the basal dimerisation of the PDK1 PH domains. The PH domain 
homodimer population (Fig. 4D) was localised at the PM and was reduced by LY294002 treatment or mutation of 
the PH domain. The loss of the homodimers at PM was most significant in the case of the R466A/K467A-PHPDK1 
mutant.
These data revealed that the dynamic regulation of the isolated PH domains of PDK1 was different from the 
regulation of full-length PDK1 in SKBR3 cells. PHPDK1 variants homodimerised to a level that was consistent with 
their localisation at the PM and the transient production of PtdIns(3,4,5)P3 (Fig. 4B–D), whereas the full-length 
protein did not behave in this manner (Fig. 3C). Therefore, these results indicated that the PH domain was not 
the sole domain with a role in the localisation of full-length PDK1 at the PM or its homodimerisation, high-
lighting the critical contribution of the kinase domain in the modulation of PDK1 conformational dynamics. 
Furthermore, the differences between the full-length PDK1 and isolated PH domain illustrated that, in SKBR3 
cells, PDK1 was not exclusively regulated by the acute formation of PtdIns(3,4,5)P3. Instead, other anionic phos-
pholipids would concur to the regulation of PDK1 in a kinase domain-dependent manner.
Our data demonstrates that PDK1 dimerisation by the modulation of PtdIns(3,4,5)P3 levels was the major 
determinant of PDK1 activity in NIH3T3 cells (Fig. 2C,E). However, in SKBR3 cells, where the PI3K pathway is 
dysregulated, the formation of PDK1 dimers did not concur with PtdIns(3,4,5)P3 variations (Fig. 3C). We suggest 
that the conventional model for the regulation of PDK1 activity by the transient production of PtdIns(3,4,5)P3 
is incomplete, as it does not account for the regulation of PDK1 in cells with a dysregulated PI3 kinase pathway.
PDK1-Akt/PKB heterodimerisation and downstream activation of Akt/PKB correlates with 
PDK1 homodimer formation in SKBR3 cells. To determine how the aberrant production of PDK1 
homodimers in SKBR3 cells influenced downstream substrates activation, we monitored the phosphoryla-
tion of two PDK1 substrates Akt/PKB and SGK1. Previously, we had shown that Akt/PKB activation required 
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PDK1-Akt/PKB heterodimerisation after binding to PtdIns(3,4,5)P310. We proceeded in determining their 
interaction by coexpressing, in SKBR3 cells, eGFP-myc-PDK1 and mCherry-Akt/PKB (Figs 5A and S2C). We 
determined that the population of PDK1-Akt/PKB heterodimers (Fig. 5B) correlated with the formation of 
PDK1 homodimers observed in Fig. 3C. Similar to PDK1 homodimerisation, the heterodimer population of 
WT-PDK1-Akt/PKB increased upon EGF stimulation. The PtdIns(3,4,5)P3 binding-defective mutation K465A 
did not prevent the heterodimerisation of PDK1 with Akt/PKB. Following the same pattern than WT-PDK1, the 
interaction of T513E-PDK1 with Akt/PKB showed an enhanced heterodimerisation upon activation. We demon-
strated the relevance of the R466A/K467A mutation in signalling propagation, since the binding of the R466A/
K467A-PDK1 mutant to Akt/PKB was significant, again correlating with the elevated ED of the PDK1 homodimer 
detected for the same mutant (Fig. 3C).
The enhanced interaction of all the PDK1 variants with Akt/PKB upon stimulation led in every case to an 
increase of Akt/PKB phosphorylation at its activation loop T308 (Fig. 5C). On the contrary, PI3K inhibition 
inhibited Akt/PKB T308 phosphorylation upon stimulation. The PDK1 mutation K465A did not prevent the 
EGF-triggered increase in T308 phosphorylation, which was consistent with the fact that this mutation did not 
obstruct either the localisation of full-length PDK1 K465A to the PM (Fig. 3B) or the increase in PDK1-Akt/PKB 
heterodimerisation (Fig. 5B). Finally, a significant increase in T308 phosphorylation was observed with both the 
activating mutant T513E and the R466A/K467A mutant compared to WT-PDK1, specifically under basal condi-
tions (Fig. 5Ca,g,j). This correlated with the fact that T513E increased PDK1 activity and that the R466A/K467A 
mutation induced the formation of PDK1-Akt/PKB heterodimers in basal conditions (Fig. 5B).
To test whether the activation of PDK1 due to the mutation of R466A/K467A could also impact more endog-
enous substrates other than Akt/PKB, we investigated the phosphorylation status of endogenous SGK1 at its 
T-loop (T256) (Figs 5D and S9). Activation of SGK1 is known to be dependent on PI3K activation and the pro-
duction of PtdIns(3,4,5)P3 and requires its hydrophobic motif phosphorylation by mTORC234,35. However, unlike 
Akt/PKB, the kinase itself does not have a PH domain to directly interact with PtdIns(3,4,5)P335. Figure 5D shows 
a similar effect for SGK1: We observed the enhanced phosphorylation of SGK1’s T-loop upon stimulation with 
EGF in a PI3K-dependent manner upon expression of WT PDK1. Furthermore, as observed with Akt/PKB, 
PDK1 R466A/K467A mutant also increased the phosphorylation of SGK1 under basal and stimulated conditions 
(Fig. 5D).
Altogether, the data obtained in both NIH3T3 and SKBR3 suggest that, in addition to the well-established 
requirement for PtdIns(3,4,5)P3, the binding of PDK1 to other anionic phospholipids is also critical in the reg-
ulation of PDK1 downstream substrates. More specifically, while PDK1 interaction with PtdIns(3,4,5)P3 would 
trigger downstream substrate activation, the binding to anionic phospholipids through K466/R467 would be 
inhibitory.
Molecular conformations of PDK1 PH domains homodimers binding to PtdIns(3,4,5)P3 and/
or PtdSer. Molecular modelling and docking experiments were performed (Supplementary Information) 
to understand the molecular mechanisms whereby PDK1 dynamics would be differentially regulated by binding 
to PtdIns(3,4,5)P3 and PtdSer. This approach also determined the binding site for these anionic phospholip-
ids. The binding of PtdIns(3,4,5)P3 and PtdSer were modelled on isolated PDK1 PH domain. The experiments 
showed that both anionic phospholipids recognised the same site on the PDK1 PH domain, albeit through dif-
ferent interactions and affinities (Fig. 6A). These results indicated that contrary to previous propositions6 the 
two phospholipids could not bind concomitantly to the same PH domain. The obstruction of PtdSer in the bind-
ing of PDK1 PH domains in GUV containing PtdIns(3,4,5)P3 (Fig. 1), was therefore unlikely to be due to the 
two phospholipids binding to the same PH domain. An alternative explanation was that PHPDK1 could bind to 
PtdSer and PtdIns(3,4,5)P3 as a dimer with each PH monomer binding to a different phospholipid. By perform-
ing protein-protein docking experiments we identified three possible PH domain homodimer conformers (C1, 
C2 and C3) formed by interacting with different combination of PtdSer and PtdIns(3,4,5)P3 binding to the PH 
domain pocket (Fig. 6B,C). The unstructured N-terminal linkers that mediate association to the kinase domains 
are also presented in Fig. 6B to evaluate the positioning of the kinase domain in the various conformers (red 
segments). The C1 conformation is associated only with one PtdSer molecule bound to one of the PH domains 
in the dimer while the other PH domain remained unoccupied. In C1, the relative positioning of the two PH 
domains did not allow for the simultaneous binding of two phospholipids at the same time at the membrane. 
Furthermore, the localisation of the linkers to the kinase domains suggested a close proximity of the two kinases 
(see the closed angle of 49°). Similar to C1, the C3 conformer arises when only one lipid was bound to one PH 
domain in the dimer, but in the case of C3 the lipid was PtdIns(3,4,5)P3. Both C1 and C3 could potentially adopt a 
C2 conformation by binding to either another PtdSer or a PtdIns(3,4,5)P3 with the empty remaining PH domain. 
The C2 conformation was compatible with a full access to both lipid sites at the membrane. Contrary to the C1 
conformation, the linkers in C2 were at maximum distance and angle (178°). This shows that the kinase domains 
in C2 were much further apart than in the C1 conformation, and could be in a position allowing the access of 
the substrates to the kinase active sites. In this condition, the C2 conformer would be compatible with an active 
conformation of the PDK1 homodimer. It is worth noting that while the angles between the conformers C2 and 
C3 are the same, the complexes bear a different geometry and might not have the same activity.
In light of these results, we suggest (Fig. 6D) that prior to stimulation, PDK1 homodimers would bind to the 
abundantly available PtdSer (and from our biochemical data possibly also PtdIns(4,5)P2) in an inactive C1 con-
formation. This event would permit PDK1 recruitment to the PM, but due to close proximity of the two kinase 
domains, C1 conformation would remain inactive. Upon growth factor stimulation and increase in PtdIns(3,4,5)
P3 levels at the PM, the further interaction of C1 with PtdIns(3,4,5)P3 via its unoccupied PH domain would 
trigger a change in conformation towards an active C2 conformer. The separation of the two kinases in the C2 
homodimer would allow accessibility to substrates and hence downstream activation. The molecular modelling 
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data also predicted that both the binding of two PtdIns(3,4,5)P3 or a non-lipid-binding state (where both PH 
domains are empty) would also trigger the active C2 conformation of the PDK1 homodimers. These results 
were of great significance since they were compatible with our biochemical findings where both PtdIns(3,4,5)
P3-triggered active PM homodimers as well as cytoplasmic (unbound) PDK1 homodimers, were capable of phos-
phorylating downstream substrates like Akt/PKB and SGK1.
The molecular mechanisms that would lead to the disassociation from the PM have not yet been identified. 
Our work and others suggest that it would likely involve the autophosphorylation of T513 and S410. We suggest 
that electrostatic repulsion would be a likely mechanism for triggering the loss of electrostatic binding to anionic 
phospholipids. Our molecular modelling data (Table 2) showed that the phosphorylation of T513 prevented the 
formation of the C1 conformer, suggesting that the presence of phospho-T513 would not be compatible with 
an inactive conformation of the PDK1 homodimer. Table 2 also shows that in the C3 conformer both S410 and 
T513 are closer to the inositol binding site than other conformations. This suggests that C3 might be a transition 
conformer that would occur following the loss of binding to one of the PtdIns(3,4,5)P3. The autophosphorylation 
of the residues S410 and T513 in the C3 (positioned closer to the anionic phospholipid binding site than in other 
conformations) could trigger repulsion from the PM.
Discussion
Previously, we had identified PDK1 homodimerisation as a central component of its acute regulation and, 
showed, by in situ FRET-FLIM, that PDK1 homodimerised in the cytoplasm of COS7 cells in a PtdIns(3,4,5)P3 
dependent manner13. In that work we suggested that the autophosphorylation of T513 upon stimulation might 
lead to the production of active PDK1 monomers through disruption of the inactive homodimers13.
The current refinement of our FRET-FLIM methodology23 permitted a deeper understanding of the complex 
mechanisms underpinning the regulation of PDK1. By monitoring the conformational dynamics of the PDK1 
T513E mutant in situ in NIH3T3 (Fig. 2C) and SKBR3 cells (Fig. 3C) we observed that the T513E mutation did 
not lead to the disassembly of the PDK1 homodimers, but generated an increase in a homodimer population 
correlating with the activation of its downstream substrates (Akt/PKB and SGK1) (Figs 2C,E and 5C,D). This 
may be interpreted in two ways. Firstly, that the PDK1 conformer requires a transition to an activated homodimer 
conformation prior to downstream substrate phosphorylation. Secondly, that PDK1 homodimerises in more than 
one conformation. We suggest that PDK1’s autophosphorylation at the T513 residue, triggered upon PM translo-
cation, could be a switch or a stabilising factor of the conformational change. Work by Kang et al. suggested, using 
co-immunoprecipitation of the isolated PDK1 PH and kinase domains, the presence of more than one possible 
PDK1 homodimer conformation22. They proposed a key role for the residue T513 in the formation of different 
dimers.
Our recent quantification of the PDK1 homodimerisation affinity, determined by the effective intracellular 
dissociation constant KD
eff  of PDK1 homodimerisation in SKBR3 cells, also demonstrated the presence of more 
than one homodimer conformation23. In this latter work, PDK1 homodimerisation was detected by time 
resolved-FRET between GFP- and Cherry-tagged PDK1. From these measurements, we established that the effec-
tive intracellular dissociation constant at basal conditions ((KD
eff )basal = 49 µM) was greater than post stimulation 
((KD
eff )EGF = 11 µM). The explanation for the decrease in the effective KD upon stimulation could be the contribu-
tion of a FRET-inactive PDK1 homodimer population (a dimer population that does not FRET), versus the 
FRET-active PDK1 homodimer population. The FRET-inactive dimer would correspond to a conformer geome-
try unfavourable to the efficient transfer of energy. This can issue from the variability in the orientation of the 
chromophores, a parameter which, in addition to the distance between FRET partners, also defines efficient 
transfer of energy. The results from the de Las Heras paper23 support the idea of PDK1 homodimer species with 
different conformations, coexisting at equilibrium with their relative abundance being dependant on the activa-
tion signal.
We suggest that the homodimer conformers with different topologies are a more effective mechanism of reg-
ulating PDK1 rather than the pre-assumed monomeric forms. This effective mechanism may provide a refined 
control of PDK1 activity by permitting a broader array of anionic phospholipids binding to the various topolo-
gies. The occurrence of inactive PDK1 homodimers could be explained by a transition ‘primed’ conformer spe-
cies: PDK1 has been shown to be constitutively autophosphorylated on its activation loop (S241) independently 
of growth factor stimulation18. Therefore, in its inactive conformation, the PDK1 homodimer would be phospho-
rylated on the activation loop but auto-inhibited prior to stimulation. This would allow for a rapid activation of 
PDK1 upon growth factor stimulation. Such behaviour is well established in other AGC kinases, such as PKCs. 
The members of this family are fully phosphorylated (primed) at their activation sites but autoinhibited by a pseu-
dosubstrate sequence prior to stimulation36. Our molecular model (Fig. 6) provides the possible conformation of 
an inactive PDK1 homodimer, prior to PtdIns(3,4,5)P3 binding and autoinhibitory configuration where the close 
Monomer A-Monomer B distances (Å) C1 C2 C3
Ser410 – Binding pocket 44 33 31
Ser410 – Thr513 40 39 41
Thr513 – Binding Pocket 30 37 29
Thr513 – Thr513 15 48 43
Ser410 – Ser410 31 52 64
Table 2. Distances between residues approximated to the closest number.
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proximity of the kinases would hinder the interaction with substrates (Fig. 6 dimer C1). The possibility of dimeric 
PH domains allows a combinatory binding of various anionic lipids that would not be feasible with monomeric 
PDK1, thus providing a refined regulatory step for its activation.
By exploiting the spatial and conformational dynamics of PDK1 and its PH domain mutants (K465A and 
R466A/K467A), we identified the differential role of the binding of anionic phospholipids as a molecular switch of 
the inactive to the active PDK1 conformations. The in vitro affinity measurements of isolated PDK1 PH domains 
indicated that the affinity for PtdSer is two to three orders of magnitude lower than for PtdIns(3,4,5)P3 (Fig. 1). 
We showed that the mutation K465A inhibits the binding to PtdIns(3,4,5)P3 and PtdIns(4,5)P2 but not PtdSer, 
and that, conversely, the mutation R466 A/K467A prevents the interaction of PtdSer and PtdIns(4,5)P2, but not 
PtdIns(3,4,5)P3. Therefore, despite the close proximity of the residues K465, R466 and K467 in PDK1 PH domain, 
the role of different anionic phospholipids in cells can be distinguished by using these differential mutations. 
The results from the sFCS experiments confirm the specific binding of PDK1 PH domain to PtdIns(3,4,5)P3 
containing GUVs. The presence of PtdSer in the same GUV interfered with the PHPDK1 binding to PtdIns(3,4,5)
P3, suggesting that the close proximity of PtdSer to the PtdIns(3,4,5)P3–bound PHPDK1 facilitated the association 
of PtdSer. Since our molecular model (Fig. 6A) established that the docking cavity cannot simultaneously accom-
modate PtdIns(3,4,5)P3 and PtdSer as previously proposed6, our results suggest that PDK1 may associate to both 
lipids as a dimer, with each PH unit binding a different lipid.
The weaker in-vitro affinity of the PDK1 PH domain for PtdSer compared to PtdIns(3,4,5)P3, raises the 
question whether, in the cell, the PtdSer-PH domain interaction is still strong enough to recruit PDK1 to the 
plasma membrane. In unstimulated cells (low PIP3 levels), K465A PHPDK1, binds PtdSer but not PtdIns(3,4,5)
P3 and was distributed at the plasma membrane, albeit at a slightly lower level than WT PHPDK1 (Fig. 4B). As 
expected, K465A PHPDK1 did not associate to the membrane upon PtdIns(3,4,5)P3 increase. On the other hand, 
the PtdSer binding-defective mutant, R465A/K466A PHPDK1, did bind PtdIns(3,4,5)P3 in-vitro (Fig. 1A) and in 
the cell, and homodimerized upon the increased levels of PtdIns(3,4,5)P3 (Fig. 4C). This mutant (R465A/K466A) 
was recruited to the plasma membrane (Fig. 4B) but at much lower levels than all other PHPDK1 variants. This 
highlights the relevance of the PtdSer - PH domain interaction, implying that it has a significant contribution 
in recruiting the PDK1 to the PM even in low PtdIns(3,4,5)P3 conditions. We note, however, than besides this 
interaction, when considering the full PDK1 protein, it is also important to take into account the role of the kinase 
domain in PDK1 intracellular localisation, as shown in Figs 3B and 4B.
Our model demonstrates that PtdIns(3,4,5)P3 and PtdSer bind to a PDK1 PH-PH dimer, with each anionic 
phospholipid binding to one PH domain. Moreover, it predicts the formation of three types of PHPDK1 homodi-
mers with various propensities to interact with anionic phospholipids. Briefly, the C1 conformer binds to PtdSer 
(only one of the two PH binds); C2 conformer binds to two anionic phospholipids, (PtdSer-PtdIns(3,4,5)P3) or 
(PtdIns(3,4,5)P3-PtdIns(3,4,5)P3); the C3 conformer binds only to PtdIns(3,4,5)P3 (only one of the two PH binds).
In addition to the regulation by anionic phospholipids, the post-translational modification of the PH domains 
by T513 phosphorylation can affect PDK1 activation in a PH domain dependent manner. Binding affinity assays 
and sFCS data showed that the activating PH domain mutation T513E induced the loss of PHPDK1 specific binding 
to PtdIns(4,5)P2 and PtdSer and a strong reduction to PtdIns(3,4,5)P3 (Fig. 1B,D), therefore suggesting that the 
activating effect of T513 phosphorylation would be through the disassociation of PDK1 from the PM, thereafter 
promoting PDK1 interaction with its downstream substrates.
By monitoring the localisation and the conformational dynamics of full-length PDK1 in NIH3T3 cells, by 
FRET-FLIM, we confirmed the interplay of the anionic phospholipids. PDK1 translocation to the PM upon stim-
ulation induced a PtdIns(3,4,5)P3 binding-dependent increase in homodimerisation. This increment was corre-
lated with an increase in downstream substrate phosphorylation. These results suggested that activated PDK1 
homodimers upon stimulation were involved in the activation of the downstream substrates. We observed that 
the loss of PM binding (R446A/K467A mutant), also elicits a strong constitutive dimerisation of PDK1 promoting 
downstream substrates phosphorylation (Fig. 2C,E). These data imply that PDK1 homodimer formation occurs 
through two independent mechanisms; one dependent on the binding to PtdIns(3,4,5)P3 at the PM and the other 
in response to the loss of the PM binding (through the R446A/K467A mutation). In both cases, the formation 
of PDK1 homodimers is correlated with the activation of its downstream substrate Akt/PKB. This suggested 
that these homodimers are similar in conformation and their activation state. We propose that the binding to 
PtdIns(3,4,5)P3 is responsible for the activation of PDK1 by forming PDK1 activated homodimers. Conversely, 
the anionic phospholipids binding to residues R466/K467 prior to PtdIns(3,4,5)P3 formation (in basal condi-
tions), are therefore responsible for maintaining PDK1 in an inactive conformation.
The abundance of PtdSer and PtdIns(4,5)P2 and the fact that PtdSer can cooperate with PtdIns(3,4,5)P3 to 
target PDK1 PH domain to the PM (Fig. 1D), as observed in other PH domains37,38, suggest that these anionic 
phospholipids are responsible for the negative regulation of PDK1 through binding to R466/K467. Furthermore, 
the R466A/K467A mutant resulted in a loss of its specific cellular localisation without a significant effect on the 
formation of total dimer population. This implies that the homodimers of PDK1 are differentially regulated by 
anionic phospholipids, a prerequisite for the refined regulation of PDK1. The association with PtdSer (and possi-
bly PtdIns(4,5)P2) increases the membrane residence time of the full-length protein and may affect its affinity for 
PtdIns(3,4,5)P3. These effects could provide PDK1 with a search mechanism for PtdIns(3,4,5)P3, similar to that 
proposed for GRP1PH 39. This regulation mechanism would also be compatible with the micro-domain compart-
mentalisation during the initial stages of PI3K signalling and the constrained lateral diffusion exhibited by PDK1’s 
immediate downstream target Akt/PKB40. Besides, PtdSer may contribute to the clustering of the phosphoinos-
itides, which could enhance the binding of PDK1 to the membrane, promoting dimerization of this protein.
To determine the effect of the dysregulation of the PI3K pathway on the regulation of PDK1, we utilised 
SKBR3 cells that have constitutively elevated PtdIns(3,4,5)P3 levels. We showed that PDK1 regulation was per-
turbed in this cell line. Growth factor stimulation still resulted in activated PDK1 homodimer formation (Fig. 3C). 
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Binding and activation of the downstream effectors Akt/PKB and SGK1 (Fig. 5C,D) was also triggered. However, 
the inhibition of the PI3K pathway due to the pre-elevated PtdIns(3,4,5)P3 levels did not affect dimer forma-
tion, suggesting that under dysregulated conditions, PtdIns(3,4,5)P3 does not behave as the molecular switch. 
Essentially, all mutants K465A, R466A/K467A and T513A elicited a PDK1 homodimerisation (Fig. 3C), which 
correlated with downstream substrates activation (Fig. 5C–D), indicating the formation of activated homodimers. 
The overall population of PDK1 homodimers was mainly located at the PM, irrespective of the PH domain muta-
tions (Fig. 3D). This suggested that the kinase domain had a significant influence on the localisation and dynam-
ics of a cellular environment exhibiting a dysregulated PI3K pathway (SKBR3 cells). Contrary to the full-length 
PDK1, the PHPDK1 wild type and its mutants behaved as predicted in a regulated PI3K pathway (as in NIH3T3 
cells) (Fig. 4). Therefore, the kinase domain is a major determinant in the regulation of PDK1 not only in terms of 
conformational dynamics but also through its localisation at the PM.
This finding corroborates with Komander et al. who have also suggested that full-length PDK1 localisation in 
cells did not strictly follow the occurrence of PtdIns(3,4,5)P3 at the PM unlike the isolated PDK1 PH domains5. 
They postulated that PDK1 could be sequestered in the cytosol possibly by binding to soluble inositol phospho-
lipids IP5/IP6. It is not clear whether this sequestration would involve the binding of monomers or dimers of 
PDK1, and how the presence of the kinase domain would influence this sequestration, but it could be part of the 
mechanism that distinguishes the behaviour of PDK1 in SKBR3 from NIH3T3 cells.
In summary, our results reveal that PDK1 homodimerises in response to an increase in PtdIns(3,4,5)P3 levels 
and that the activated PDK1 dimers phosphorylate both membranous (Akt/PKB) and cytoplasmic (SGK1) sub-
strates. Our observations establish the cooperative association of PtdSer with PtdIns(3,4,5)P3 in recruiting PDK1 
to the PM, but they have opposite effects on PDK1 activation. Our results indicate that membrane-binding to 
anionic lipids other than PtdIns(3,4,5)P3, would stabilise PM-associated PDK1 in a homodimer conformation 
where the catalytic site would be sequestered from potential substrates. The enhancement in PtdIns(3,4,5)P3 levels 
would induce a dual binding of the PDK1 homodimer from PtdSer only (C1, Fig. 6) to PtdSer- PtdIns(3,4,5)P3 or 
PtdIns(3,4,5)P3-PtdIns(3,4,5)P3 and a change in conformation of PDK1 consistent with an activated conforma-
tion (C2, Fig. 6). The phosphorylation of T513 leads to a transition C3 conformation and dissociation from the 
membrane where the PDK1 dimer adopts the C2 type activated conformation.
Finally, 41 missense substitutions had been found in PDK1 linked to various types of cancers (Cosmic data-
base). Correlated to our results, one of these residues (R466) was found mutated 3 times; in brain (R466Q), breast 
(R466Q) and colon (R466W)41. Our findings indicate that a physiological alteration of the R466/K467 site in cells 
mimicking the effect of the mutant 466 A/467 A, and altering the binding to PtdSer or PtdIns(4,5)P2, would lead 
to the constitutive activation of PDK1 and potentially to a significant effect in different types of cancer. Therefore, 
detailed characterisation of this site, and its previously unappreciated role in PDK1 downregulation, would enable 
defining a novel therapeutic strategy where a constitutively activated dimer of PDK1 could be rendered inactive 
by small molecules that would drive its conformation towards an inactive membrane-bound conformer.
Materials and Methods
Reagents and antibodies. LY294002 in solution, recombinant human epidermal growth factor (EGF) and 
Mowiol 4–88 were purchased from Calbiochem. Recombinant human platelet-derived growth factor (PDGF), 
Lipofectamine LTX & Plus Reagent, penicillin/streptomycin (P/S), Sodium Pyruvate, GlutaMax Supplement and 
cell culture media were obtained from Life Technologies. Bovine serum albumin (BSA), sodium borohydride 
and the rest of reagents were purchased from Sigma-Aldrich. Antibodies against total AKT (mouse panAKT 
#40D4), phospho-AKT (rabbit pThr308 #244F9 and rabbit pSer473 #D9E), phospho-PKC(pan) (rabbit γThr514 
#9379) and HA- and myc-tags (mouse #6E2 and rabbit #71D10, respectively) were purchased from Cell Signaling 
Technology; the antibody against tubulin (mouse α-Tubulin) was purchased from Sigma-Aldrich. Secondary 
antibodies for infrared detection (IRDye 680RD anti-mouse #926-32211, and IRDye 800CW anti-rabbit #926-
68070) and the corresponding blocking buffer were obtained from LI-COR Inc (Nebraska). Glass-bottomed #1.5 
35-mm dishes were obtained from MatTek Corporation (MA).
Lipids. 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine (18:1 DOPC), 1-hexadecanoyl-2-(9
Z-octadecenoyl)-sn-glycero-3-phospho-L-serine (18:1-16:0 POPS) and 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[
phosphoinositol-3,4,5-trisphosphate (18:1 PtdIns(3,4,5)P3) were purchased from Avanti Polar Lipids (Alabaster, 
AL).
Constructs. The eGFP-myc-PDK1, HA-PDK1-mCherry were cloned as described elsewhere13.
mRFP-HA-PKB constructs were cloned as described elsewhere13.
GFP-Lact-C2 was obtained from AddGene. Cloning of the K465A and R466A/K467A mutants of 
PDK1 and PHPDK1, mRFP-HA-PKB, mCherry-6xGly-GFP, mCherry-LactC2-P2A-GFP, and GRP1PH and 
Lyn11-FKBP2-mRFP is described in detail in the supplementary methods.
Cell culture. Transfection, serum starvation procedure and sample preparation methods are described in the 
supplementary methods.
Vesicle preparation. Giant Unilamelar Vesicles were prepared by spontaneous swelling as described in25.
Western blots. Quantification of IR Western blots was done on an Odyssey Imaging system (Li-Cor Inc, 
Nebraska). Antibodies against panAKT and α-Tubulin were used as internal control for the quantification of Akt 
phosphorylation and SGK1 phosphorylation, respectively. Lysis conditions for western-blotting and procedures 
are described in the supplementary methods.
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Confocal imaging and FRET-FLIM. Confocal and lifetime images were acquired on a Leica TCS SP5 con-
focal scanning microscope through a 63×/1.30 objective. Samples were excited using a 488 nm and 543 CW 
lasers and fluorescence images were acquired in the 500–550 and the 575–750 nm windows. Lifetime imag-
ing was performed using a TCSPC system (SPC-830, Becker & Hickl, Germany) with a pulsed laser (Mai-Tai, 
Spectra-Physics) tuned at 890 nm for excitation. Time-resolved fluorescence detection was performed in the 
500–550 nm. Further information on the set-up can be found in the Supplementary Information. Experimental 
and analytical procedures for image segmentation, ED quantification of the accessible PtdIns (3,4,5)P3 and PtdSer 
and calculation of the PM to cytoplasm ratio are detailed in the Supplementary Methods.
The position of the GFP and mCherry in PDK1 was relevant for the FRET measurements. Tagging PDK1 at 
the at the same terminal resulted in low FRET efficiency, presumably due to an unfavourable dimer geometry 
since our previous work had pointed towards a homodimer conformation where the N and C termini of the con-
stituent monomers would be in close proximity to each other13.
Scanning fluorescence correlation spectroscopy (sFCS). sFCS is a single-molecule sensitivity tech-
nique that allows the diffusion coefficient of a molecule to be determine as the membrane-bound molecule dif-
fuses on the surface of a vesicle42,43. sFCS was applied to study the diffusional behaviour and intermolecular 
interactions of fluorescently-labelled proteins bound to GUVs (Fig. S1A). A water immersion objective HCX 
PL APO 63×/1.20 W CORR Lbd Bl (Leica) on a confocal Leica SP5 was employed and confocal detection of the 
emission using the avalanche photodiodes fitted to the DD X1 output port of the microscope. To excite eGFP 
tagged species we used the 488 nm line from an Ar+ laser. The average power density at the sample plane was 
50 kW/cm2. eGFP emission was detected through a 500–530 nm bandpass filter. Photon arrival times were regis-
tered using an SPC-830 TCSPC card (Becker & Hickl, Germany), which also registered the pixel, line and frame 
signals from the scanner. An HRT-82 Eight Channel Router (Becker & Hickl, Germany) was required to spec-
trally tag the signal of the detected photons. An external clock signal at 20 MHz was used (Fig. S1B)
The imaging mode at the microscope was set to xt (line-scanning) and the scanning frequency was 1400 Hz. 
The scanning length spanned over 16.64 μm, binned in 64 pixels of 260 nm each. The equatorial section of the 
GUVs was scanned for 5 min. The Becker & Hickl files encoding the arrival of the photons were decoded using 
an in-house Matlab routine (available at request). The xt photon trace was aligned to correct for the vesicle drift 
(Fig. S1C) and the resulting photon time trace was fit to a 2D diffusion model with a minimal lag-time given by 
the inverse of the scanning frequency:
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where N is the average number of molecules in the focal volume, τ is the lag-time, τD is the diffusion time of the 
molecule and S ratio of the axial (zo) to the radial (beam waist, ωo) 1/e2 dimensions of the confocal volume. ωo 
and zo were obtained after calibrating the volume using a dye with known diffusion (Alexa 488, D ≈ 430 μm2/s at 
25 °C). Finally, the diffusion coefficient is D = ωo2/(4τD). All uncertainties are indicated as SEM.
Molecular Modelling. Molecular modelling is described in the supplementary methods.
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